Efficacy and safety of Tripterygium glycosides as an add-on treatment in adults with chronic urticaria: a systematic review and meta-analysis

AbstractContext Tripterygium glycosides (TG), a traditional Chinese medicine, has been used to treat chronic urticaria (CU) in China, and the evidence of TG for CU needs to be updated thoroughly.Objective To systematically evaluate the efficacy and safety of TG combined with H1-antihistamine (H1-AH)...

Full description

Bibliographic Details
Main Authors: Ming Li, Yan Li, Lujing Xiang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Pharmaceutical Biology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13880209.2023.2169468
_version_ 1797234818314928128
author Ming Li
Yan Li
Lujing Xiang
author_facet Ming Li
Yan Li
Lujing Xiang
author_sort Ming Li
collection DOAJ
description AbstractContext Tripterygium glycosides (TG), a traditional Chinese medicine, has been used to treat chronic urticaria (CU) in China, and the evidence of TG for CU needs to be updated thoroughly.Objective To systematically evaluate the efficacy and safety of TG combined with H1-antihistamine (H1-AH) in adults with CU.Methods Eligible randomized controlled trials were searched in eight databases until May 31, 2022, including CNKI, WanFang, VIP, SinoMed, PubMed, Cochrane Library, Embase, and Web of Science. The search terms included urticaria, Tripterygium, Lei Gong Teng, and Leigongteng. Rev Man 5.3 and Stata 12.0 were used for statistical analysis.Results A total of 27 studies with 2788 patients were included. The pooled results showed that TG plus H1-AH was superior to H1-AH alone in cure rate (RR = 1.37, 95% CI = 1.15 to 1.63, p = 0.0003), total efficacy rate (RR = 1.40, 95% CI = 1.30 to 1.50, p < 0.00001), pruritus (MD = −0.32, 95% CI = −0.54 to −0.11, p = 0.003), wheal number (MD = −0.31, 95% CI = −0.55 to −0.07, p = 0.01), wheal size (MD = −0.32, 95% CI = −0.46 to −0.19, p < 0.00001), and the serum level of immunoglobulin E (SMD = −1.39, 95% CI = −2.42 to −0.36, p = 0.008). Moreover, adverse events between two groups were mild, and their incidences were not significantly different.Conclusions The combination of TG and H1-AH is a promising and safe treatment for adults with refractory CU. Further high-quality studies are needed to confirm the evidence.
first_indexed 2024-03-09T00:08:54Z
format Article
id doaj.art-2987d91c5a814d0c9e88e449046faabc
institution Directory Open Access Journal
issn 1388-0209
1744-5116
language English
last_indexed 2024-04-24T16:38:06Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Pharmaceutical Biology
spelling doaj.art-2987d91c5a814d0c9e88e449046faabc2024-03-29T11:10:26ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162023-12-0161132433610.1080/13880209.2023.2169468Efficacy and safety of Tripterygium glycosides as an add-on treatment in adults with chronic urticaria: a systematic review and meta-analysisMing Li0Yan Li1Lujing Xiang2Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaDepartment of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaDepartment of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, ChinaAbstractContext Tripterygium glycosides (TG), a traditional Chinese medicine, has been used to treat chronic urticaria (CU) in China, and the evidence of TG for CU needs to be updated thoroughly.Objective To systematically evaluate the efficacy and safety of TG combined with H1-antihistamine (H1-AH) in adults with CU.Methods Eligible randomized controlled trials were searched in eight databases until May 31, 2022, including CNKI, WanFang, VIP, SinoMed, PubMed, Cochrane Library, Embase, and Web of Science. The search terms included urticaria, Tripterygium, Lei Gong Teng, and Leigongteng. Rev Man 5.3 and Stata 12.0 were used for statistical analysis.Results A total of 27 studies with 2788 patients were included. The pooled results showed that TG plus H1-AH was superior to H1-AH alone in cure rate (RR = 1.37, 95% CI = 1.15 to 1.63, p = 0.0003), total efficacy rate (RR = 1.40, 95% CI = 1.30 to 1.50, p < 0.00001), pruritus (MD = −0.32, 95% CI = −0.54 to −0.11, p = 0.003), wheal number (MD = −0.31, 95% CI = −0.55 to −0.07, p = 0.01), wheal size (MD = −0.32, 95% CI = −0.46 to −0.19, p < 0.00001), and the serum level of immunoglobulin E (SMD = −1.39, 95% CI = −2.42 to −0.36, p = 0.008). Moreover, adverse events between two groups were mild, and their incidences were not significantly different.Conclusions The combination of TG and H1-AH is a promising and safe treatment for adults with refractory CU. Further high-quality studies are needed to confirm the evidence.https://www.tandfonline.com/doi/10.1080/13880209.2023.2169468Randomized controlled trialstraditional Chinese medicineeffectivenessadverse event
spellingShingle Ming Li
Yan Li
Lujing Xiang
Efficacy and safety of Tripterygium glycosides as an add-on treatment in adults with chronic urticaria: a systematic review and meta-analysis
Pharmaceutical Biology
Randomized controlled trials
traditional Chinese medicine
effectiveness
adverse event
title Efficacy and safety of Tripterygium glycosides as an add-on treatment in adults with chronic urticaria: a systematic review and meta-analysis
title_full Efficacy and safety of Tripterygium glycosides as an add-on treatment in adults with chronic urticaria: a systematic review and meta-analysis
title_fullStr Efficacy and safety of Tripterygium glycosides as an add-on treatment in adults with chronic urticaria: a systematic review and meta-analysis
title_full_unstemmed Efficacy and safety of Tripterygium glycosides as an add-on treatment in adults with chronic urticaria: a systematic review and meta-analysis
title_short Efficacy and safety of Tripterygium glycosides as an add-on treatment in adults with chronic urticaria: a systematic review and meta-analysis
title_sort efficacy and safety of tripterygium glycosides as an add on treatment in adults with chronic urticaria a systematic review and meta analysis
topic Randomized controlled trials
traditional Chinese medicine
effectiveness
adverse event
url https://www.tandfonline.com/doi/10.1080/13880209.2023.2169468
work_keys_str_mv AT mingli efficacyandsafetyoftripterygiumglycosidesasanaddontreatmentinadultswithchronicurticariaasystematicreviewandmetaanalysis
AT yanli efficacyandsafetyoftripterygiumglycosidesasanaddontreatmentinadultswithchronicurticariaasystematicreviewandmetaanalysis
AT lujingxiang efficacyandsafetyoftripterygiumglycosidesasanaddontreatmentinadultswithchronicurticariaasystematicreviewandmetaanalysis